This article will provide a pathophysiologic basis for the assessment of critically ill children who have developed disorders of urine volume. The anatomical and pathophysiologic causes of oliguria and polyuria are considered. The physiologic basis for the use of urinary sodium and osmolarity as a guide to the assessment of patients with disorders of urine volume are discussed in detail. In addition, guidelines for the management of children with acute renal failure, with particular emphasis on the consideration for nutritional support of these patients, is discussed as a part of the comprehensive approach to this problem. This article emphasizes an understanding of the pathophysiology of salt and water excretion by the kidney as a foundation to the diagnosis and management of patients with oliguria and polyuria.
In a critically ill patient, the volume or rate of urine excretion is used, frequently, as an index of cardiovascular stability, cardiac output, and peripheral perfusion. In fact, in some instances, the adequacy of parenteral fluid therapy is assessed and adjusted according to urine output. Such assumptions concerning urine output and judgments about fluid therapy are not only an oversimplification of complex renal physiology, but also hazardous for patient management. Under homeostatic conditions, 20 -25 percent of cardiac output is distributed to the kidneys, 500 cc/minute in an adult. Approximately 20 percent of this volume is filtered by the glomerulus (100 cc/minute) and, over 24 hours, the proximal tubule is presented 144 liters of glomerular filtrate (i.e., potential urine) and 20,160 mEq (460 g) of sodium. The tubules and collecting ducts reabsorb 98-99 percent of this filtrate (i.e., 142 liters of fluid and 456 g of sodium) which results in a final urine output of 2 liters/day which contains 4 g of sodium. In most circumstances, the kidney will react to maintain intravascular volume and plasma tonicity by balancing the processes of filtration, reabsorption, and excretion. For example, by autoregulation of resistance in the afferent and efferent arteriole, glomerular filtration rate (GFR) can be maintained through a wide range of blood pressures and renal perfusion [1] . Moreover, the intact kidney responds to a variety of stimuli in a reasonably predictable and reproducible manner so that an assessment of urinary electrolytes can be helpful in evaluating patients with oliguria or polyuria.
However, pathophysiologic alterations in the production or reabsorption of tubular fluid render urine output a poor index of renal function. If GFR is maintained but the reabsorptive processes are enhanced by a reduction in intravascular volume, as in simple dehydration, or diminished renal perfusion, as occurs in congestive heart failure, a patient may be relatively oliguric while renal function is quite normal. Alternatively, GFR may be severely reduced but a concomitant reduction in the volume of tubular fluid which is reabsorbed will result in a normal or increased urinary volume. In fact, in the extreme example of non-oliguric acute renal failure (ARF), the amount of urine excreted may equal the entire volume of glomerular filtrate produced. Thus, it becomes apparent that the oliguric patient may have relatively normal renal function and the polyuric patient could have acute or chronic renal failure. Assessment of renal function in children and adolescents must be based, therefore, on absolute values or changes in the blood levels of urea nitrogen (BUN) and creatinine (Cr) and/or the clearance of creatinine or inulin [2, 3] .
In a stable, euvolemic state, a child or adolescent with normal renal function and intact kidneys will generally excrete 1.5-3 cc/kg/hour of urine. This estimate is derived from the volume of urine expected in a pediatric patient receiving parenteral fluids at a maintenance rate of infusion. Maintenance fluid therapy is designed to maintain water and electrolyte homeostasis with minimal renal compensation [4] . The volume of fluid needed for maintenance therapy is composed of two parts: (1) evaporative (insensible) losses and (2) urinary losses. Evaporative or insensible water requirement is approximately one-third of total maintenance requirement and consists of electrolyte-free water. During maintenance fluid therapy, urinary losses are expected to have an osmolarity of 300 mOsm/L and a specific gravity of 1.010. Caution must be taken that the patient can achieve an isotonic urine and, under homeostatic conditions, urinary losses account for two-thirds of total maintenance fluid requirement. Estimates of total maintenance requirement can be made from the following table:
1-10 kg 100 cc/kg/day 11-20 kg 1,000 cc + 50 cc/kg > 10/day 21-80 kg 1,500 cc + 20 cc/kg > 20/day
This sliding scale approach is based on the concept that water and electrolytes are lost in direct proportion to the kilocalories expended. If 120 ml of water is required for every 100 Kcal metabolized and if water of oxidation is 17 ml/100 Kcal and preformed water is 3 ml/100 Kcal, it becomes apparent that, in this system, 100 ml of water are needed for each 100 Kcal expended. Thus, the calculations from the sliding scale provided an estimate of caloric expenditures, maintenance fluid requirements, and expected urine volume under homeostatic conditions. ASSESSMENT OF OLIGURIA Based on the expected urine volume, a child or adolescent excreting less than 0.8 cc/kg/hour of urine should be assessed for oliguria. Classically, the causes of oliguria have been divided into pre-renal, renal, and post-renal categories. However, such a classification is neither physiologically based nor accurate. Accordingly, the classification shown in Table 1 forms the basis of our approach to this problem.
Anatomic Causes First consideration should be given to the obstruction or occlusion of the major anatomical components of the renal system: artery, vein, ureter, and bladder. It must be emphasized that oliguria will not result from the occlusion of the artery, vein, or ureter to only one kidney, unless the contralateral kidney is absent or non-functional. Thus, one must suspect bilateral renal artery, vein, or ureteral obstruction if these sites are to be implicated as the cause of oliguria. Renal artery thrombosis is rare in children although occasionally encountered in newborn infants as a complication of umbilical artery catheterization. The usual clinical presentation for this problem is acute hypertension in a young infant. (2) acute renal failure, and (3) non-physiologic anti-diuretic hormone secretion. The renal response in each of these clinical settings is highly reproducible and well defined. Although each of these conditions will cause a fall in urine volume below expected levels, the urinary constituents, especially sodium and osmolarity, are characteristic and can be used diagnostically when the kidney has not been manipulated pharmacologically with vasodilators or diuretics ( Table 2) . Decreased Intravascular Volume or Impaired Renal Perfusion A decrease in intravascular volume results in a decrease in cardiac output and renal hypoperfusion. Thus, the renal response to either decreased intravascular volume or a primary fall in renal perfusion is similar. In this situation, the renal Fractional Sodium Excretion =Plasma Na + Plasma Creatinine tubules remain intact and a marked increase in the reabsorption of solutes and water occurs throughout the nephron. An increase in filtration fraction (GFR/renal plasma flow) produces an increase in peritubular oncotic pressure and results in enhanced reabsorption of tubular fluid in proximal tubular segments. The decrease in renal perfusion stimulates the secretion of renin by the juxtaglomerular apparatus, and thereby aldosterone production is increased and produces sodium reabsorption from the distal tubule. Release of anti-diuretic hormone in response to decreased intravascular volume increases water reabsorption in the collecting duct. Thus, the urinary sodium concentration is quite low (< 10 mEq/L) and the urinary osmolarity is high (> 500 mOsm/L). In premature infants and children less than one year of age, urinary sodium < 20 mEq/L and osmolarity < 400 mOsm/L would be expected values [7] . Clinical conditions which are associated with decreased intravascular volume include dehydration secondary to vomiting, diarrhea, nasogastric drainage, or third space losses. Repletion of intravascular volume with appropriate fluid therapy in this clinical setting will result in increased urine output. Occasionally, children with nephrotic syndrome will become oliguric while edematous because of decreased intravascular volume secondary to reduced plasma oncotic pressure. Remission of the nephrotic syndrome or the infusion of albumin to restore intravascular volume will alleviate the oliguria in these children. Patients with congestive heart failure have a primary decrease in renal perfusion because of diminished cardiac output despite adequate or expanded intravascular volume. In this situation, therapy should be aimed toward improved cardiac function rather than repletion of intravascular volume. Similarly, children with acute glomerulonephritis [8, 9, 10, 11, 12, 13] or hemolytic uremic syndrome [14, 15, 16, 17, 18] have increased intravascular volume but diminished renal perfusion which occurs at a level of the glomerular capillary loop. In patients with acute glomerulonephritis, the increase in renal vascular resistance is caused by the intense inflammatory reaction in the glomeruli and in patients with hemolytic uremic syndrome micro-thrombi occlude the glomerular capillaries. The oliguria associated with these conditions resolves only as the renal disease improves and heals. In both of these "renal" causes, the tubules remain intact and the renal response in terms of urinary sodium concentration and osmolarity is physiologically identical to the "pre-renal" causes such as dehydration and congestive heart failure. Thus, the use of the term "pre-renal" to describe the renal pathophysiologic response to decreased intravascular volume or diminished renal perfusion is inaccurate and confusing. Lastly, patients with the hepato-renal syndrome will have oliguria and urinary sodium concentrations which are low and urinary osmolarity which is high. In fact, it would appear that this syndrome is a vasomotor phenomena rather than an intrinsic renal lesion. The correction of the oliguria in these patients occurs only when the liver failure improves, which is rare. Acute Renal Failure (ARF)
The renal response to a fixed or established acute renal insult is complex [19, 20, 21, 22] . Although the specific mechanisms involved may vary according to the type and intensity of the acute renal injury, an acute loss of GFR and paralysis of tubular function are the characteristic features of acute renal failure (ARF). An increase in renal vascular resistance [23, 24] combined with back-leak of tubular fluid [25, 26, 27, 28, 29] and intratubular obstruction [30, 31, 32, 33] result in a nearly complete cessation of GFR. Clinically, this is reflected in an increase in both BUN and serum creatinine on a daily basis. It is important to remember that although GFR is virtually non-existent early in ARF, the absolute value of serum creatinine will not reflect the profound loss of GFR because this value increases only 0.5-1.5 mg/dl/day. Thus, in patients with ARF, the rate of change in serum creatinine, rather than the actual value itself, is the best index of the level of GFR, and a progressive increase in BUN and creatinine is a characteristic feature of this syndrome. Changes in BUN will be affected by a variety of factors such as catabolic rate, protein load, and medications, including steroids and antibiotics. Consequently, the rate of change in BUN is not a specific index of the level of GFR. The second feature which is characteristic of ARF is diminished tubular function. Ironically, the term "acute tubular necrosis" is a better description of tubular function than anatomic morphology in ARF [34] . Thus, the small volume of urine which these patients produce has a high sodium concentration (> 50 mEq/L) and elevated FENa (> 2 percent). Since both the concentration and dilution of tubular fluid require intact tubular function, these patients have urine which is isotonic to plasma (i.e., urinary osmolarity of 280-300 mOsm/L and urine-to-plasma osmolar ratio of 0.8-1.0). In ARF, a dilute urine would be as unexpected as a concentrated urine and an isotonic urine is the most consistent feature of this syndrome. In fact, a low urinary sodium concentration and FENa have been reported in some patients with ARF induced by contrast media.
The clinical conditions which are associated with the development of ARF include hypotension/shock, renal ischemia, nephrotoxins, drugs, hyperuricemia, asphyxia, and sepsis [35, 36, 37, 38, 20, 39] . Most often, more than one potential causative agent can be identified, but in some circumstances, ARF will develop without a clearly defined renal insult. In this regard, several factors should be remembered: (a) dehydration or volume depletion will increase the susceptibility to develop ARF from a minor insult [40, 41] ; (b) hypoxia combined with acidosis will produce a more profound loss of renal function than either factor alone; (c) nephrotoxins, especially aminoglycoside antibiotics, usually produce a non-oliguric ARF initially with oliguria developing later in the course of the renal injury [42, 43, 40, 44] , and some drugs may potentiate the relative nephrotoxicity of other agents [45] ; and (d) sepsis may produce ARF from endotoxins without concomitant hypotension [46] .
Studies in both experimental animals [47, 48, 49, 50, 51] and man [52, 53, 54] have indicated that the fall in GFR can be attenuated significantly or even eliminated by administration of saline, mannitol, furosemide, or other agents prior to the renal insult. Interestingly, the common denominator among all of these perturbations which will protect against the development of ARF is the initiation of a solute diuresis prior to the renal injury [51, 55, 56] . Thus, in those clinical situations where an acute renal insult is anticipated, such as renal vascular surgery, open heart surgery using cardiopulmonary by-pass, or administration of large volumes of contrast media, the patient should be well hydrated with isotonic fluid and/or a natriuretic agent should be given prior to the renal insult.
At the present time, the treatment of ARF consists of supportive care until the kidney recovers from the acute insult. In this regard, several potential problems must be anticipated and managed: (1) fluid therapy, (2) electrolyte problems, (3) acidosis, (4) hypertension, (5) dialysis, and (6) Two major electrolyte problems are encountered commonly in patients with ARF. Hyponatremia (serum sodium < 130 mEq/L) may be present at the time the diagnosis of ARF is made or may occur during the course of therapy. When present at the onset of ARF, hyponatremia is usually the result of overzealous administration of fluids in an attempt to increase urine output prior to the recognition of oliguric ARF. When a fall in serum sodium occurs during the management of a child with ARF, it is usually because of an overestimate of evaporative fluid requirement. In both cases, hyponatremia has occurred because of excessive administration of fluids and not the excretion of sodium. If the hyponatremia is profound (serum sodium < 120 mEq/L) and the patient has central nervous system manifestations such as obtundation or seizures, a rapid correction of the hyponatremia would be indicated and the serum sodium can be increased by 10 mEq/L with the infusion of hypertonic (3 percent) saline. This solution contains 450 mEq/L of sodium, and 12 ml/kg will increase serum sodium by 10 mEq/L. It must be emphasized that (1) the administration of sodium is not usually required to correct the hyponatremia associated with ARF, (2) fluid restriction is the primary and essential mode of therapy, and (3) the infusion of sodium may be hazardous for the patient and lead to volume expansion, hypertension, and congestive heart failure.
Because the kidney is the primary source for potassium excretion and because the extra-renal mechanisms which are required for potassium adaptation occur slowly over several weeks, hyperkalemia is frequently encountered in patients with ARF 157]. Often the insult which causes the ARF produces significant systemic tissue damage with the release of intracellular potassium from necrotic cells or in response to acidosis. Since potassium ions move out of cells as hydrogen ions move into cells, serum potassium levels are not a direct index of total body potassium and must be interpreted with respect to acid-base status. For example, a serum potassium of 6 mEq/L is less ominous in a patient with a mild metabolic acidosis (pH 7.30; bicarbonate, 15 Hypertension is frequently encountered in children with acute renal failure. While judicious administration of fluids will lessen the degree and frequency of hypertension in children with ARF, a substantial proportion of patients will require treatment to avoid developing hypertensive encephalopathy. The management of hypertensive crisis or accelerated hypertension requires special consideration in children [58] . Heart failure, papilledema, and/or encephalopathy mandate prompt and intensive antihypertensive treatment. Hypertensive encephalopathy in children may be manifested as headache, irritability, or convulsions. These symptoms appear to be related more to the rapidity of the rise in blood pressure than to a specific level of pressure. Papilledema and retinal hemorrhages and exudates are less commonly seen in children with acute symptomatic hypertension than in adults [59] . Children with acute elevations in blood pressure may convulse and yet not manifest papilledema or significant funduscopic changes. Diazoxide, a non-diuretic sulfonamide derivative, is the drug of choice for the treatment of acute or accelerated hypertension in children [60] . It should be administered rapidly (in less than 30 seconds) in an intravenous dose of 5 mg/kg/dose (maximum, 300 mg per dose). The onset of action is rapid and the effect on blood pressure dramatic. The patient rarely becomes hypotensive, and the effect may last several hours to a day, during which time additional medications, such as hydralazine, can be added to obtain long-term control of blood pressure. Repeated administration of diazoxide may be associated with sodium retention, and prolonged use should, therefore, be combined with a natriuretic drug, such as furosemide; frequently, a combination of a diuretic, such as furosemide, and diazoxide are used from the onset.
Parenterally administered hydralazine (0.2 mg/kg/dose, intramuscularly or intravenously) is also an effective and potent antihypertensive agent [58] . Its onset of action is one to two hours, and its duration of action is four to eight hours. Unfortunately, nausea, vomiting, and headache commonly occur in children treated with parenteral hydralazine, and these side effects may confuse the clinical picture when hypertensive encephalopathy is present. In situations in which intravascular volume overload is the prominent factor and renal function is relatively well preserved, such as acute glomerulonephritis [61] , intravenous administration of furosemide (2 to 10 mg/kg/dose) may prompt a brisk diuresis and concomitant lowering of the blood pressure. Sodium nitroprusside is a potent and effective parenterally administered antihypertensive [62] . This [68, 69, 70] demonstrated that the intravenous infusion of essential amino acids and glucose would result in positive nitrogen balance, better healing of wounds, maintenance of weight, amelioration of uremic symptoms, and diminished levels of blood urea nitrogen in post-operative adult patients with ARF. In 1973, Abel and associates [71] provided controlled evidence of the efficacy of the administration of essential amino acids with hypertonic glucose in ARF. These investigations compared the outcome of 28 patients treated with amino acids and hypertonic glucose to 25 patients given an isocaloric, isovolemic glucose infusion. Patients with congestive heart failure, endocarditis, hepatic failure, sepsis, persistent hypertension, or urinary obstruction were excluded from the study. In addition, the two groups were randomized for factors which might alter the course of ARF such as age, levels of BUN or creatinine prior to treatment, oliguria, and the interval from injury to intravenous therapy. In this relatively homogenous group of patients, the infusion of amino acid with hypertonic glucose had a dramatic effect on recovery from the episode of ARF. During the period of acute renal shutdown, the mortality rate was reduced from 56 percent in the glucose-treated patients to 25 percent in the patients receiving amino acids and glucose. Among the patients who required dialysis only 18 percent of those given glucose lived, whereas 65 percent of those treated with the amino acid-glucose mixture survived. In patients given amino acids, the serum creatinine concentration peaked on day two of therapy while this value continued to rise for seven days after initiation of treatment with glucose alone. Utilizing a slightly different amino acid mixture, in a larger group of 129 patients, Baek and associates (72] also noted an impressive decline in mortality from 70 percent in glucose-treated patients to 46 percent in patients given amino acids during an episode of post-operative ARF. In 1975, Leonard and co-workers [73] reported improved nitrogen balance but no effect on survival or duration of renal insufficiency in a small group of 20 patients with ARF treated with amino acids and glucose or glucose alone. Unfortunately, this was a heterogenous group of both medical and surgical patients, and the treatment groups were not randomized for factors which might alter the outcome. In fact, the amino acid-glucose-treated patients were older, had more pre-existing disease, and were more catabolic prior to initiation of therapy. Similarly, Abel et al. [74] failed to demonstrate increased survival with amino acid therapy for patients with acute renal failure complicated by congestive heart failure, hepatic failure, sepsis, or persistent hypertension. Unfortunately, there was no glucose-treated control group with similar complications. Thus, the results of administration of amino acids to patients with ARF is mixed. One possible explanation would be that the potential effect of this therapy in the more severely ill patients is obscured because of their heightened catabolic state and the limited ability to supply calories and nutrients which can be utilized for renal repair and regeneration. Because of limited clinical experience and conflicting reports concerning the efficacy of this modality, definitive indications for initiation of amino acid therapy in ARF cannot be established. The potential beneficial effect of increased caloric and nutrient content must be evaluated in the context of a given patient's clinical setting, local expertise in the performance of parenteral alimentation in children and adolescents, and the risks of this procedure, which include catheter placement injuries, sepsis, hyperglycemia, and electrolyte abnormalities [72, 73] .
It should be remembered that children may be able to take enteral nutrition during an episode of ARF. In such circumstances, the diet should be modified to account for the ARF, but the caloric intake should be maximized to offset the catabolic state associated with ARF. In large part, this will consist of restricting protein intake to 0.5-1g/kg/day, limiting sodium to 2 g/day, and reducing potassium to 1.5 g/day. Although fluid intake will be restricted, free access to carbohydrates and fats should be encouraged. Once dialysis is initiated, the dietary and fluid restriction can be liberalized, or if continuous peritoneal dialysis is used, the diet can be relatively unrestricted. Thus, clinical judgments concerning nutritional needs and dialysis therapy must be made together and individualized, based on a specific clinical setting and needs of the patient.
Some patients will develop ARF without oliguria [42, 44] . In the clinical setting of non-oliguric ARF, the urine constituents are the same as those in oliguric patients, but the etiology is more often related to nephrotoxic antibiotics, particularly the aminoglycoside category [43] . Experimental data would suggest that non-oliguric ARF develops when cortical perfusion is better preserved relative to total renal blood flow [40] . Although it has been proposed that potent diuretics can convert an oliguric ARF to a polyuric ARF, such therapy does not seem warranted for several reasons: (a) the use of furosemide and ethycrinic acid in high doses in patients with ARF is associated with significant and sometimes permanent hearing loss [75, 76] , (b) conversion from oliguric to polyuric ARF does not result in more rapid return of GFR [75, 76] , and (c) the eventual prognosis is unchanged [75, 76] . In patients with non-oliguric ARF, careful replacement of urine losses must be incorporated into the fluid management regime to avoid electrolyte disturbances.
The prognosis for patients with an established acute renal insult is dependent largely on the cause of ARF. With the availability of acute hemo and peritoneal dialysis for the replacement of kidney function, it is apparent that patients die with, not because of, ARF. Thus, the magnitude and severity of the total body insult become the limiting factors for most patients with ARF [77, 78] . Recovery from oliguric ARF is heralded by an increase in urine output which occurs, on average, 10 to 14 days after the acute injury. In some situations the period of oliguria may be only two to three days, whereas some patients have ARF for 30 days or more. It is relatively difficult to predict the onset of recovery and, for patients with prolonged oliguria, the potential for recovery of renal function is even more difficult to assess. Once urine output reappears, there is usually an increase in volume for several days as GFR returns faster than tubular function and a significant diuresis may ensue. The BUN and serum creatinine does not usually fall until the diuresis has been established for several days. However, data from experimental animals [26] and man [27] would suggest that a significant amount of solute and water leaks back across the injured tubular epithelium during the early phase of recovery from ARF. Thus, the back leak of tubular fluid containing urea and creatinine across the tubule into the blood would result in the BUN and serum creatinine being an underestimate of GFR during the early period of recovery from ARF. The recovery of renal function is dependent on reperfusion of the previously vasconstricted kidney [47, 79, 80, 24] . Thus, care must be taken to assure the maintenance of intravascular volume, cardiac output, and renal perfusion to promote recovery from ARF. In this regard, the diuresis which occurs during this phase of ARF should be replaced unless the patient has clear clinical signs of volume overload or edema formation. Moreover, drugs or procedures which may result in diminished renal perfusion should be avoided if possible. Most patients have a full recovery of renal function, although maximal concentrating ability may be impaired for several years [77, 81, 78] . Non-Physiologic Anti-Diuretic Hormone Secretion Oliguria may be a mode of presentation for critically ill children with nonphysiologic (inappropriate) anti-diuretic hormone (ADH) secretion because of the low renal solute load in these patients. Although this pathophysiologic process is frequently thought to be complex and clinically confusing, it is based on a relatively simple concept: the persistent excretion of a concentrated urine in the absence of physiologic stimuli for ADH release. If conceptualized from this perspective, the clinical findings in this syndrome are easy to understand, and the term nonphysiologic ADH secretion is a clearer description of the syndrome than the more conventional term "syndrome of inappropriate ADH secretion" (SIADH). The secretion of ADH by the posterior lobe of the pituitary gland is closely regulated, under homeostatic conditions, by osmolar and volume receptors. A 2 percent increase in plasma osmolarity will result in the release of enough ADH to produce anti-diuresis [82] , while a 1.2 percent decrease in plasma osmolarity will suppress ADH secretion sufficiently to produce a diuresis [83] . Baroreceptors, located in the carotid sinus [84] and left atrium [85] modulate ADH release in response to changes in intravascular volume. Although these physiologic monitors usually act in the same direction, there is evidence that regulation of volume takes precedence over osmolarity when the two parameters conflict. Patients with non-physiologic ADH secretion have a persistently concentrated urine even though intravascular volume is normal or increased and plasma osmolarity is normal or decreased. Continual release of ADH results in increased water reabsorption from the collecting duct into the plasma. Consequently, these patients have a concentrated urine (urine osmolarity > 500 mOsm/kg, urine-to-plasma osmolar ratio of 2.0) and a diluted plasma (plasma osmolarity < 280 mOsm/L, serum sodium < 140 mEq/L, BUN < 15 mg/dl, and uric acid < 2 mg/dl). The reabsorption of water from the collecting duct into the plasma also results in intravascular volume expansion which causes a depression of proximal tubular sodium reabsorption and a natriuresis (urinary sodium > 50 mEq/L, FENa > 2 percent). Several aspects of this sequence of events require additional clarification: (a) neither the retention of water nor the quantity of sodium lost in the urine can completely account for the profound hyponatremia which may occur in some patients, and it has been proposed that some sodium enters cells where it becomes osmotically inactive [86] ; (b) hyponatremia occurs only when excess free water has been administered and retained; conversely, if predominantly isotonic fluid is given or fluid is restricted early, hyponatremia may not occur [87] ; (c) in the face of severe hyponatremia, urine osmolarity may not be very high but the urine will not be maximally dilute (less than 100 mOsm/L) and, therefore, is inappropriately concentrated relative to plasma osmolarity [87] . Thus, when a patient has a persistently concentrated urine despite a fall in serum sodium and osmolarity combined with an elevated urine sodium concentration, the diagnosis of nonphysiologic ADH secretion should be entertained: the normal or low serum osmolarity indicates that the osmolar receptors are not stimulated and the increased urine sodium implies that intravascular volume is replete or expanded; therefore, the baroreceptors are not stimulated and, thus, the persistently concentrated urine must be the result of non-physiologic ADH secretion.
This syndrome was described first in patients with bronchogenic carcinoma [88] . Subsequently, a variety of clinical conditions have been associated with this process. In the intensive care setting, this syndrome is frequently seen in patients with pulmonary problems [89] (pneumonia, ventilator therapy), intracranial lesions [90] (tumor, trauma, meningitis), in post-operative patients [87] , and secondary to drugs (vincristine, chlorpropamide, cyclophosphamide, morphine) [91] . It is important to remember that emotional stress and pain may cause the release of ADH, and in some patients no cause will be evident. The anticipation of the development of this syndrome in appropriate clinical settings has important implications for fluid therapy. In patients with meningitis, head trauma, or after general anesthesia, only one-half to two-thirds of usual maintenance fluids should be given, since it is likely that serum ADH levels will be high and, consequently, the patients will not be able to dilute their urine to specific gravity 1.010 or less.
Since the primary determinant of this syndrome is persistent reabsorption of water with consequent dilution of plasma and intravascular volume expansion, the principal mode of therapy is fluid restriction. The clinical complication of this syndrome, particularly hyponatremia, can be entirely prevented by fluid restriction even though there is persistent secretion of ADH. In fact, in most patients, fluid restriction alone is sufficient to correct hyponatremia and should be considered the basis of therapy. In cases of severe hyponatremia, hypertonic (3 percent) saline should be given to acutely raise serum sodium in order to diminish central nervous system complications such as coma or convulsions. Hypertonic saline infusion results in additional volume expansion and diminished proximal sodium reabsorption so that the effectiveness of this therapy is transient, at best, and may result in hypertension or congestive heart failure. The combination of potent diuretic agents and hypertonic fluid infusions may be effective in patients with severe hyponatremia [92] . The diuretic agents produce urine which contains 75-100 mEq/L of sodium and chloride. Thus, the infusion of a more hypertonic solution in a volume equal to the urine output should result in an increase in serum sodium without additional volume expansion. Because of the rapid shifts in fluids and electrolytes which occur with this therapy, it should be instituted with caution. Other therapeutics have been used in patients with chronic SIADH [93] , but these are rarely applicable for acutely ill patients.
Throughout this approach to the assessment of a child or adolescent with oliguria, we have emphasized the use of urinary sodium concentration and osmolarity as an integral part of the diagnostic process. In this regard, two important factors must be underscored. The urinary sodium concentration and osmolarity are a valid index of the pathophysiologic cause of oliguria only if the urine sample is obtained before the patient has been given: (1) a significant fluid challenge (20 cc/kg/hour) or (2) diuretic agents (mannitol, furosemide, ethycrinic acid). In some situations, one may not be able to differentiate the cause for the oliguria, and two manipulations can be attempted. First, assuming that the patient does not have overt evidence of fluid overload such as pulmonary or peripheral edema, a volume challenge (20 cc/kg/hour) of isotonic fluid should be administered. Since the fluid is isotonic, the potential hyponatremia associated with a fixed renal injury or non-physiologic ADH secretion should not be exacerbated and the patient with oliguria secondary to volume depletion or diminished renal perfusion should manifest an increase in urine output. Similarly, the administration of furosemide (4 mg/kg/intravenously) would be expected to result in a diuresis in patients with volume depletion but would have little or no effect for patients with ARF. It must be remembered that both of these maneuvers will invalidate the use of urinary sodium concentration, FENa, or urinary osmolarity in differentiating the cause of oliguria.
ASSESSMENT OF POLYURIA The development of urine output which exceeds expected values (> 4 cc/kg/hour) is termed polyuria. Children are considerably more susceptible to the problems of volume overload and the development of polyuria in response to increased intravascular volume because small volumes of fluid can produce a greater degree of volume expansion in children than they can in adults. This condition requires careful evaluation and may arise from two major sources: (1) excretion of a fluid load or (2) a tubular defect for sodium and/or water reabsorption. As shown in Table 3 , an assessment of the changes in the plasma values of sodium and osmolarity compared with these same values in the urine may be quite helpful in evaluating the possible causes of polyuria. In polyuric patients, the urinary concentration of sodium and osmolarity must be interpreted in the context of the sodium concentration and osmolarity of the fluids being administered to the patient. Thus, specific values for serum and urine sodium and osmolarity have not been given in Table 3 , but relative changes have been indicated.
Excretion of Fluid Load
If a patient has received an excess volume of fluid which must be excreted (20 cc/kg/hour or twice maintenance fluid requirement), the patient will appear clini- The second category of causes for polyuria is a tubular defect in salt and/or water reabsorption. In contrast to the patients who are excreting a volume load and appear clinically well hydrated, patients in this category will maintain a high urine flow rate despite appearing clinically volume-depleted. In patients with a salt-losing nephropathy, a defect in maximal urinary concentrating ability is usually also present, and these patients excrete a large volume of a urine with an increased sodium content and with an isotonic osmolarity even when intravascular volume is low or renal perfusion diminished. This type of renal tubular defect may be due to anatomic (cystic diseases, partial ureteral occlusion), pathologic (interstitial nephritis, non-oliguric ARF, recovery phase of oliguric ARF, post-obstructive diuresis, DKA), or pharmacologic (osmotic diuresis, loop-acting diuretics, drugs) lesions. In most instances, the specific cause for the salt and water diuresis will be apparent from the associated clinical findings. The major complications associated with these causes of polyuria are related to fluid and electrolyte abnormalities, particularly hyponatremia, if urine losses are replaced with hypotonic solutions; hypokalemia and hypocalcemia occur because of the excess urinary loss of these electrolytes, and dehydration/hypotension develops because of the limited concentrating ability. Therapy is aimed at the specific cause which is identified and the replacement of fluid losses to prevent volume depletion.
Diabetes insipidus (DI) is a tubular defect in water reabsorption due to a lack of ADH release from the posterior pituitary (central DI) or a failure of the kidney to respond to ADH (nephrogenic DI) [93] . In either case, polyuria occurs because of the inability to re-claim tubular fluid presented to the collecting duct. Consequently, these patients produce a persistently dilute urine which has a low urinary sodium concentration since there is no defect in sodium reabsorption. The excretion of large volumes of dilute urine results in hypernatremia and hypertonicity of plasma. In many respects, this syndrome is defined as the inverse of non-physiologic ADH secretion: the production of a persistently dilute urine despite increasing serum sodium and osmolarity. Central DI may result from an injury to the posterior pituitary where ADH is stored or the hypothalamus where ADH is produced. Central DI has been associated with head trauma, meningitis, tumors, and cerebral edema. Since the renal tubule is intact, these patients respond to ADH or one of its analogs, 1-desamine-8D-arginine vasopressin (dDAVP), by producing a concentrated urine. When central DI is fully established, it is difficult to administer sufficient fluids to maintain the patient in a homeostatic state, and ADH should be given. Care must be taken to adjust fluids appropriately once ADH is effective to avoid wide and rapid swings in serum sodium. Because of greater dependability, aqueous pitressin or dDAVP are preferred to pitressin tannate in oil. dDAVP can be used only if the nasopharyngeal mucosa is intact.
Nephrogenic DI results in the same perturbations in serum and urine sodium and osmolarity as may be seen in patients with central DI [93] . Patients with nephrogenic DI have a tubular insensitivity to ADH which may be either hereditary or secondary to drugs [82] (methoxy-flurane, propoxyphene, lithium, or demethyl-chlortetracycline), renal parenchymal disease (chronic glomerulonephritis, sickle cell nephropathy), or electrolyte abnormalities (hypokalemia or hypercalcemia). Therapy should be directed toward elimination of the secondary causes of nephrogenic DI when possible and reduction in the renal solute load to diminish the degree of diuresis. Patients with the sex-linked hereditary disorder will require management with diuretics or prostaglandin synthetase inhibitors. This article has outlined an approach to the assessment of critically ill children who have developed disorders of urine output. We have emphasized an understanding of the pathophysiology of salt and water excretion by the kidney as a foundation to the diagnosis and management of patients with oliguria and polyuria. Based on this approach, the causes of disorders of urine output should be readily diagnosed and effectively treated.
